Associations between tumor response to pembrolizumab and immune-related adverse events in metastatic melanoma patients

被引：0
|
作者：
Geszti, F. [1 ]
Czirbesz, K. [1 ]
Kenessey, I. [1 ]
Liszkay, G. [1 ]
机构：
[1] Natl Inst Oncol, Budapest, Hungary
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
8516
引用
收藏
页码：AB24 / AB24
页数：1
相关论文
共 50 条
  • [31] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Abdel-Wahab, Noha
    Diab, Adi
    Yu, Robert K.
    Futreal, Andrew
    Criswell, Lindsey A.
    Tayar, Jean H.
    Dadu, Ramona
    Shannon, Vickie
    Shete, Sanjay S.
    Suarez-Almazor, Maria E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1939 - 1949
  • [32] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Noha Abdel-Wahab
    Adi Diab
    Robert K. Yu
    Andrew Futreal
    Lindsey A. Criswell
    Jean H. Tayar
    Ramona Dadu
    Vickie Shannon
    Sanjay S. Shete
    Maria E. Suarez-Almazor
    Cancer Immunology, Immunotherapy, 2021, 70 : 1939 - 1949
  • [33] Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab
    Aya, Francisco
    Fernandez-Martinez, Aranzazu
    Gaba, Lydia
    Victoria, Ivan
    Tosca, Monica
    Carrera, Cristina
    Prat, Aleix
    Arance, Ana
    IMMUNOTHERAPY, 2016, 8 (06) : 687 - 692
  • [34] Association between immune-related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
    Euvrard, Romain
    Robert, Marie
    Mainbourg, Sabine
    Dalle, Stephane
    Lega, Jean-Christophe
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (02) : 369 - 379
  • [35] Association between lactate dehydrogenase levels and immune-related adverse events among patients with melanoma on immune checkpoint inhibitors
    Pan, Catherina
    Lau, William
    Kim, Daniel
    Lau, Charles
    Rowley, Rachael
    Kanwar, Ruhi
    LeBoeuf, Nicole
    Nambudiri, Vinod
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB19 - AB19
  • [36] Pembrolizumab-Induced Colitis: A Case Report of Immune-Related Adverse Events
    Hasan, Fariha
    Singh, Avneet
    Garcia, Alexander
    Mukhtar, Sameen
    Williams, Kathy N.
    Deitch, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1935 - S1935
  • [37] Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab
    Shah, N.
    Jacob, J.
    Househ, Z.
    Shiner, E.
    Baird, L.
    Soudy, H.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [38] Asthma as an Immune-Related Adverse Effect of Pembrolizumab
    Yenepalli, A.
    Diaz, L. Luna
    Eggert, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [39] Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations
    Park, Benjamin C. C.
    Narayanan, Sathya
    Gavraldis, Alexander
    Ye, Fei
    Fan, Run
    Sullivan, Ryan J. J.
    Boland, Genevieve
    Reynolds, Kerry L.
    Balko, Justin M. M.
    Carlino, Matteo S. S.
    Long, Georgina V. V.
    Zubiri, Leyre
    Menzies, Alexander M. M.
    Johnson, Douglas B. B.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [40] Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    Keraliya, Abhishek
    Bailey, Nancy D.
    Ott, Patrick A.
    Hodi, F. Stephen
    Nishino, Mizuki
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) : 1185 - 1192
12345